These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24224851)

  • 1. X-ray repair cross-complementing 1 polymorphism and prognosis of platinum-based chemotherapy in gastric and colorectal cancer: a meta-analysis.
    Wu H; Xu C; Chen G; Wang J
    J Gastroenterol Hepatol; 2014 May; 29(5):926-33. PubMed ID: 24224851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic role of XRCC1 polymorphisms on the clinical outcome of gastric cancer patients with platinum-based chemotherapy: a systematic review and meta-analysis.
    Xu J; Ma J; Zong HT; Wang SY; Zhou JW
    Genet Mol Res; 2014 Mar; 13(1):1438-46. PubMed ID: 24634242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between polymorphisms in XRCC1 gene and treatment outcomes of patients with advanced gastric cancer: a systematic review and meta-analysis.
    Cao Z; Song J; Wang J; Guo X; Yu S; Dong W
    PLoS One; 2014; 9(1):e85357. PubMed ID: 24465544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis.
    Zhang X; Jiang LP; Yin Y; Wang YD
    Tumour Biol; 2014 Jun; 35(6):5637-45. PubMed ID: 24590266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis.
    Ye F; Liu Z; Tan A; Liao M; Mo Z; Yang X
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):733-40. PubMed ID: 23299794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.
    Yin M; Yan J; Martinez-Balibrea E; Graziano F; Lenz HJ; Kim HJ; Robert J; Im SA; Wang WS; Etienne-Grimaldi MC; Wei Q
    Clin Cancer Res; 2011 Mar; 17(6):1632-40. PubMed ID: 21278243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
    Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
    Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese population.
    Gan Y; Li XR; Chen DJ; Wu JH
    Asian Pac J Cancer Prev; 2012; 13(11):5721-4. PubMed ID: 23317245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ERCC1 C118T polymorphism predicts clinical outcomes of colorectal cancer patients receiving oxaliplatin-based chemotherapy: a meta-analysis based on 22 studies.
    Qian YY; Liu XY; Wu Q; Song X; Chen XF; Liu YQ; Pei D; Shen LZ; Shu YQ
    Asian Pac J Cancer Prev; 2014; 15(19):8383-90. PubMed ID: 25339033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis.
    Cui Z; Yin Z; Li X; Wu W; Guan P; Zhou B
    BMC Cancer; 2012 Feb; 12():71. PubMed ID: 22339849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic Association between
    Zhang N; Ouyang Y; Chang J; Liu P; Tian X; Yu J
    Biomed Res Int; 2020; 2020():3520764. PubMed ID: 33150172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer.
    Lv H; Li Q; Qiu W; Xiang J; Wei H; Liang H; Sui A; Liang J
    Pathol Oncol Res; 2012 Oct; 18(4):1009-14. PubMed ID: 22549274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of XRCC1 Arg399Gln Polymorphism with Colorectal Cancer Risk: A HuGE Meta Analysis of 35 Studies.
    Forat-Yazdi M; Gholi-Nataj M; Neamatzadeh H; Nourbakhsh P; Shaker-Ardakani H
    Asian Pac J Cancer Prev; 2015; 16(8):3285-91. PubMed ID: 25921133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population.
    Tian Z; Li YL; Liu JG
    Mol Biol Rep; 2013 Jul; 40(7):4147-51. PubMed ID: 23712778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of GSTP1 Ile105Val polymorphism in clinical outcomes of chemotherapy in gastric and colorectal cancers: a systematic review and meta-analysis.
    Shen X; Wang J; Yan X; Ren X; Wang F; Chen X; Xu Y
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1285-302. PubMed ID: 27154175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The XPD Lys751Gln polymorphism has predictive value in colorectal cancer patients receiving oxaliplatin-based chemotherapy: a systemic review and meta-analysis.
    Qian YY; Liu XY; Pei D; Xu JL; Shen H; Chen XF; Liu YQ; Shen LZ; Shu YQ
    Asian Pac J Cancer Prev; 2014; 15(22):9699-706. PubMed ID: 25520091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis.
    Lu X; Xiao S; Jin C; van der Straaten T; Li X
    J Clin Lab Anal; 2012 Jan; 26(1):10-5. PubMed ID: 24833529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive values of platinum-related gene polymorphisms in gastric cancer patients on oxaliplatin-based adjuvant chemotherapy].
    Liu YP; Ling Y; Zhang YP; Liu BR
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):256-9. PubMed ID: 21418871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement.
    Li DJ; Xiao D
    BMC Cancer; 2017 Jul; 17(1):501. PubMed ID: 28743242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case-control studies.
    Yi L; Xiao-Feng H; Yun-Tao L; Hao L; Ye S; Song-Tao Q
    PLoS One; 2013; 8(10):e78071. PubMed ID: 24205095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.